Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,652.9
16.2 (0.62%)

 

  • STI Straits Times Index
    2,652.9
    16.2 (0.62%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,552.7
    16.4 (1.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,373.1
    248.9 (0.99%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,152.8
    62.2 (2.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,306.5
    160.5 (0.72%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,973.8
    7.0 (0.14%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,532.5M
  • Value: 907.4M
  • Rise: 181
  • Fall: 116
  • Unch: 511

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.500+0.035
IPS Securex0.105+0.015
LionGold0.002-
Oceanus^0.007-
Secura0.094+0.003
Synagie0.191+0.012
ThaiBev0.695+0.020
Singapore-eDev0.115-0.001
New Wave0.011-0.001
Asian Micro0.004-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 03 Jul 2020 17:07
Last (SGD): 0.320 Change: +0.005 High: 0.335 Remarks: -
Change (%): +1.59 Low: 0.310
Open 0.320 Yesterday's Close 0.315
Buy Price 0.315 Sell Price 0.320
Buy Volume ('000) 150.0 Sell Volume ('000) 29.9
Cumulative Volume ('000) 5,627.2 Cumulative Value 1,828,300
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01847 Trailing EPS (SGD) e -0.01847 NAV (SGD) b 0.0418
PE a - Trailing PE f - Price / NAV b 7.6555
Dividend (SGD) d - Cash In Hand (SGD) g 0.0232 Issued & Paid-up Shares c 260,358,000
Dividend Yield (%) d - Price / Cash In Hand g 13.793 Treasury Shares h -
Beta - 75 Daysi 0.367 R-Squared - 75 Days(%)i 0.63 Market Cap (M) 83.315
Beta - 500 Daysi 0.540 R-Squared - 500 Days (%)i 1.52 Enterprise Value (M) 77.822
Piotroski F Score 2 Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 66.7137 6-Month VWAP 0.429 Free Float (%) 33.5
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 83.315 - - 7.6555 -
Industry Medical & Biotechnology SGX 989.515 20.509 22.499 1.3084 2.063
Medical Specialties SGX 2,807.265 143.644 80.559 13.0956 0.378
Local Peer Top Glove SGX 16,164.300 132.626 75.472 14.7312 0.390
Local Peer Medtecs Intl SGX 274.705 175.439 175.530 3.2072 -
Local Peer UG Healthcare SGX 260.804 104.069 128.222 6.1404 0.192
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.207
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), TOPGLOV (Bursa), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), SUPERMX (Bursa), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), KDL MEDICAL (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), LIFE HEALTHCARE (HKEx), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.090
-21.95 %
10 Days --0.100
-23.81 %
20 Days --0.100
-23.81 %
Medium Term Return 3 Months -+0.065
+25.49 %
6 Months -+0.075
+30.61 %
1 Year -+0.025
+8.47 %
Annualised Return Annualised --
+8.47 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.175 - 0.885 Change From 1 Year Low +0.145 % Change From 1 Year Low (%) +82.86
Change From 1 Year High -0.565 % Change From 1 Year High (%) -63.84
2 Years Range 0.175 - 0.885 Change From 2 Years Low +0.145 % Change From 2 Years Low (%) +82.86
Change From 2 Years High -0.565 % Change From 2 Years High (%) -63.84
5 Years Range 0.175 - 0.885 Change From 5 Years Low +0.145 % Change From 5 Years Low (%) +82.86
Change From 5 Years High -0.565 % Change From 5 Years High (%) -63.84
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) +14.29 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.32 MB)
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 0.320 0.335 0.310 0.320 5,627,200 0.3249
02 Jul 2020 0.290 0.340 0.285 0.315 12,685,000 0.3209
01 Jul 2020 0.310 0.310 0.285 0.295 7,369,900 0.2932
30 Jun 2020 0.315 0.330 0.300 0.305 4,428,300 0.3117
29 Jun 2020 0.295 0.350 0.280 0.320 17,626,300 0.3226
26 Jun 2020 0.415 0.420 0.405 0.410 2,937,900 0.4145
25 Jun 2020 0.410 0.420 0.405 0.415 3,261,800 0.4114
24 Jun 2020 0.420 0.420 0.410 0.410 2,950,900 0.4155
23 Jun 2020 0.415 0.430 0.410 0.420 6,563,800 0.4183
22 Jun 2020 0.420 0.425 0.405 0.410 2,576,300 0.4142
19 Jun 2020 0.420 0.440 0.420 0.420 19,236,300 0.4289
18 Jun 2020 0.400 0.420 0.400 0.415 6,871,800 0.4124
17 Jun 2020 0.410 0.415 0.400 0.410 2,820,500 0.4055
16 Jun 2020 0.420 0.420 0.405 0.410 2,730,100 0.4109
15 Jun 2020 0.425 0.435 0.405 0.410 4,888,700 0.4228
12 Jun 2020 0.395 0.420 0.390 0.415 5,791,400 0.4104
11 Jun 2020 0.430 0.445 0.405 0.405 8,323,700 0.4253
10 Jun 2020 0.395 0.435 0.390 0.430 11,909,200 0.4192
09 Jun 2020 0.405 0.410 0.390 0.395 3,299,700 0.3998
08 Jun 2020 0.420 0.425 0.405 0.410 2,065,200 0.4131
05 Jun 2020 0.400 0.425 0.400 0.420 6,010,000 0.4172
04 Jun 2020 0.405 0.410 0.400 0.400 1,787,600 0.4039
Summary
Current 2 Weeks
(22 Jun 2020 to 03 Jul 2020)
0.420 0.430 0.280 0.320 66,027,400 -
Previous 2 Weeks
(08 Jun 2020 to 19 Jun 2020)
0.420 0.430 0.280 0.420 67,936,600 -
4 Weeks from
(08 May 2020 to 05 Jun 2020)
0.465 0.475 0.280 0.420 144,510,700 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.